Insider buying last 90 days
No open-market insider purchases were filed for ICLR in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every ICLR insider filing, plotted on the chart in Gekko.Open ICLR in Gekko
NASDAQ: ICLR
ICON (ICLR) Stock Analysis & Forecast
Sep 28 close
$175.57+3.24 (+1.9%)
Gekko Brief
AI summaryThis week ICON's shares rise as investors focus on backlog and guidance, with recent filings cited as supportive background alongside the move. Separately, Marram Investment Management is reported to have exited its ICLR position at breakeven, citing a shrinking moat and competitive pressure in the clinical research organization industry, while another piece flags the stock as undervalued on a third-party score.
ICLR closed at $175.57, up 1.9%, sitting above both its 50-day average of $167.44 and 200-day average of $146.85, with the 50-day above the 200-day. The GekkoIndex reads 53.1, placing it in the Neutral zone, down 3.4 over five days. Gekko Fair Value stands at $179.78, putting the current price 2.3% below that level.
The next earnings report is set for 28 October 2026, before the open, 29 days out and beyond a typical 20-trading-day holding window; the prior report on 29 July showed EPS of $2.35 against a $2.26 estimate, with an 8.2% reaction. Options activity over the past 30 days shows one unusual signal, with put premium of $1,177,800 against call premium of $52,000. Seasonality over 5 years shows a -1.3% average return across the next 20 trading days, rising in 3 of those years. Analyst coverage from 8 firms shows 6 buy, 1 hold and 1 sell ratings, with a consensus target of $185.25.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
ICON price vs fair value
Close $175.57200-day averageGekko Fair Value $179.78
ICON quick facts
- Market cap
- $13.44B
- P/E ratio
- 265.1
- Forward P/E
- 14.8
- EPS, TTM
- $0.65
- Revenue, TTM
- $8.29B
- Profit margin
- 0.3%
- Dividend yield
- —
- Beta
- 1.20
- Volume
- 1.34M avg 1.03M
- 1-year return
- +8.0%
- Typical daily move
- ±3.8%
- Typical 20-day move
- ±6.6%
- 50-day average
- $167.44
- 200-day average
- $146.85
- Next earnings
- Oct 28 before open
- Shares outstanding
- 77.15M
ICON swing-trade checklist
ICON scores 2 supportive, 3 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive3 mixed1 headwind
- Trendsupportive
Above 50 and 200-day
Close $175.57 is above the 50-day ($167.44) and 200-day ($146.85) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
53.1, Neutral
Reading 53.1 is in the Neutral zone.
See the GekkoIndex - Fair valuemixed
2.3% below
Price is within 5% of Gekko Fair Value (2.3% below).
See fair value - Smart moneyheadwind
Leans bearish
Last 30 days: 1 unusual options signal.
See smart money - Earnings risksupportive
Reports in 29 days
Next report Oct 28, 2026, 29 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
−1.3% on average
From this point in the calendar, the next 20 trading days averaged −1.3% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
ICON stock chart and price history
ICON closed at $175.57 on Sep 28, 2026, +8.0% over the past year, inside a 52-week range of $66.57 to $203.91.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +3.4%
- 3 months
- +1.5%
- 6 months
- +72.0%
- 1 year
- +8.0%
The full ICLR chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open ICLR in Gekko
Follow ICON through every session
Put ICLR on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track ICLR in GekkoFree for 7 days. No credit card required.
About ICON
ICON provides outsourced services that support the development and commercialization of new medical products. It works across the full clinical development process, from selecting compounds through Phase I-IV studies, and is recognized for managing complex, multi-stage research programs on behalf of other organizations rather than running its own drug pipeline.
The company's offerings span clinical trial management, consulting, contract staffing, and commercial strategy work such as trial design and post-market positioning. It also runs laboratory operations covering bioanalytical, biomarker, vaccine, and central lab testing, alongside services like decentralized trials, medical imaging, and real-world data analysis. Its customers include pharmaceutical, biotechnology, and medical device companies, as well as government and public health bodies, and it has formed a strategic alliance with Advarra to build a connected network of clinical trial sites.
ICON was incorporated in 1989 and is based in Dublin, Ireland, with operations extending across Europe, the United States, and other regions. Its shares are listed on the NASDAQ under the ticker ICLR.
- Listed
- NASDAQ
- Sector
- Commercial services
- Industry
- Miscellaneous commercial services
- Website
- iconplc.com
ICON GekkoIndex: the smart money zone
ICON’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 53.1, in the Neutral zone, down 3.4 points over five sessions.
53.1Neutral
Down 3.4 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 48 | −3.7% | −3.6% | ||
| Accumulation | 245 | +0.6% | −1.6% | ||
| Neutral (current zone) | 319 | 0.0% | −0.3% | ||
| Distribution | 51 | +0.6% | +5.5% | ||
| Selling | 9 | Too few readings yet | |||
Average ICLR share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the ICLR price, zone by zone.Track ICLR in Gekko
Is ICON stock overvalued? Gekko Fair Value
ICON trades 2.3% below Gekko Fair Value of $179.78, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what ICON shares are worth, recalculated every trading day.
$179.78
Gekko Fair Value, Sep 29, 2026
2.3% below fair value · About fair value
Gekko Fair Value on every chart, with the gap to price updating daily.Open ICLR in Gekko
ICON insider and Congress trading
No open-market insider purchases were filed for ICON, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in ICLR were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for ICLR, plotted on the chart in Gekko.Open ICLR in Gekko
Buybacks
ICON has been buying back its own shares.
- Bought back, quarter ended Dec 31, 2025
- $500.0M
- As a share of market cap
- 3.72%
- Trailing four quarters
- $1.28B
From company filings.
Unusual options activity last 30 days
1signal, 4% of the flagged premium in calls.
Latest: Bearish flow on Sep 2, $1.23M in unusual premium.
Hedge funds and billionaires quarter ended Jun 30
0of the funds Gekko tracks hold ICLR.
0added0opened0trimmed4sold out
Every signal with its contract, strike and premium, and which funds are on each side.Unlock in Gekko
ICON earnings: next date and track record
ICON reports on Oct 28, 2026, before the open (29 days away), and beat the EPS estimate in 6 of its last 8 reports.
Next earnings report
Oct 28, 2026
Expected before the open, 29 days away
- EPS estimate
- $2.69
- Revenue estimate
- $2.01B
6 of 8reports beat the EPS estimate
±11.2%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $2.35 est $2.26 | $2.06B est $2.00B | −8.2% |
| May 27, 2026 | $2.22 est $2.16 | $2.11B est $1.98B | +20.2% |
| Feb 25, 2026 | $0.00 est $3.31 | — | +2.0% |
| Oct 22, 2025 | $3.31 est $3.28 | $2.04B est $2.01B | −6.9% |
| Jul 23, 2025 | $3.26 est $3.18 | $2.02B est $1.98B | +20.7% |
| Apr 30, 2025 | $3.19 est $3.09 | $2.00B est $2.01B | −2.7% |
| Feb 19, 2025 | $3.43 est $3.43 | $2.04B est $2.04B | +7.0% |
| Oct 23, 2024 | $3.35 est $3.84 | $2.03B est $2.04B | −21.8% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
ICON stock forecast and analyst price targets
Analysts’ average 12-month price target for ICON is $185.25, +5.5% from the last close, from 8 firms rating the stock in the last 90 days.
$185.25consensus 12-month target, +5.5% from the last close
Now $175.57Avg $185.25
Low $160High $220
Each firm’s latest rating in the last 90 days: 8 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 18 | Citi | $175 | −0.3% |
| Sep 17 | Truist Financial | — | — |
| Aug 2 | TD Cowen | $197 | +12.2% |
| Jul 31 | Robert W. Baird | $194 | +10.5% |
| Jul 31 | Citi | $180 | +2.5% |
−0.3%average 20-day move after past Neutral readings
−1.3%average move over the next 20 trading days in the last 5 years
±3.8%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
ICON seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, ICON averaged −1.3% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +4.1% | 3 of 5 |
| Next 10 trading days | +3.4% | 4 of 5 |
| Next 15 trading days | +1.9% | 3 of 5 |
| Next 20 trading days | −1.3% | 3 of 5 |
| Next 30 trading days | −0.9% | 3 of 5 |
For scale, ICLR’s typical 20-trading-day move in either direction is about 6.6%.
ICON market cap and key statistics
ICON’s market cap is $13.44B, with a P/E ratio of 265.1 and revenue of $8.29B over the last twelve months.
Valuation
- Market cap
- $13.44B
- P/E ratio
- 265.1
- Forward P/E
- 14.8
- EPS, TTM
- $0.65
- Gekko Fair Value
- $179.78
Trading
- Volume
- 1.34M
- Avg volume, 20 days
- 1.03M
- 52-week high
- $203.91
- 52-week low
- $66.57
- Shares outstanding
- 77.15M
Financials
- Revenue, TTM
- $8.29B
- Profit margin
- 0.3%
- Return on equity
- 0.3%
- Quarterly earnings growth, YoY
- −63.3%
Risk and income
- Beta
- 1.20
- Typical daily move
- ±3.8%
- Typical 20-day move
- ±6.6%
ICON stock news this week
Coverage of ICON this week reads positive: 2 positive, 0 neutral and 1 negative headlines.
ICON peers
ICON’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| SHOPShopify | Neutral | 5.0% above |
| CTASCintas | Neutral | 11.5% above |
| PYPLPayPal | Accumulation | 4.6% below |
| XYZBlock | Accumulation | 2.5% above |
| CPAYCorpay | Accumulation | 18.1% below |
| FISVFiserv | Buying | 40.6% below |
A peer links to its own page where one exists.
ICON stock FAQ
What is ICON’s market cap?
ICON’s market cap is $13.44B at the Sep 28, 2026 close of $175.57, with 77.15M shares outstanding. The shares trade on a P/E ratio of 265.1.
What is the ICON stock forecast?
The consensus analyst 12-month price target for ICON is $185.25, +5.5% from the last close. Of the 8 firms that rated the stock in the last 90 days, 6 rate it a buy, 1 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
Is ICON stock overvalued or undervalued?
On Gekko’s estimate ICON is about fair value: the Sep 28, 2026 close of $175.57 is 2.3% below Gekko Fair Value of $179.78. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does ICON report earnings next?
ICON is expected to report on Oct 28, 2026, before the market opens (29 days away). Analysts expect earnings of $2.69 per share on revenue of $2.01B. ICON beat the earnings estimate in 6 of its last 8 reports, moving 11.2% on average across the report.
What is ICON’s 52-week high and low?
ICON’s 52-week high is $203.91 and its 52-week low is $66.57; it closed at $175.57 on Sep 28, 2026, +8.0% over the past year. Over the last five years the shares peaked at $347.72 on Jul 16, 2024.
Is ICON stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 6 items with data read as supportive (trend and earnings risk), 3 as mixed (gekkoindex, fair value and seasonality) and 1 as a headwind (smart money). The checklist is a description of current data, not a recommendation.
Is there unusual options activity in ICON?
Gekko flagged 1 unusual options signal in ICON over the last 30 days, with $52K of flagged premium in calls and $1.18M in puts. The latest, bearish flow, was on Sep 2, 2026 with $1.23M in unusual premium. The signal-by-signal table is in Gekko.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See ICON the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.